Rabbit CYP4B1 engineered for high-level expression in Escherichia coli: ligand stabilization and processing of the N-terminus and heme prosthetic group
- PMID: 12859977
- DOI: 10.1016/s0003-9861(03)00278-9
Rabbit CYP4B1 engineered for high-level expression in Escherichia coli: ligand stabilization and processing of the N-terminus and heme prosthetic group
Abstract
Modifications at the N-terminus of the rabbit CYP4B1 gene resulted in expression levels in Escherichia coli of up to 660 nmol/L. Solubilization of the enzyme from bacterial membranes led to substantial conversion to cytochrome P420 unless alpha-naphthoflavone was added as a stabilizing ligand. Mass spectrometry analysis and Edman sequencing of purified enzyme preparations revealed differential N-terminal post-translational processing of the various constructs expressed. Notably, bacterial expression of CYP4B1 produced a holoenzyme with >98.5% of its heme prosthetic group covalently linked to the protein backbone. The near fully covalently linked hemoproteins exhibited similar rates and regioselectivities of lauric acid hydroxylation to that observed previously for the partially heme processed enzyme expressed in insect cells. These studies shed new light on the consequences of covalent heme processing in CYP4B1 and provide a facile system for future mechanistic and structural studies with the enzyme.
Similar articles
-
Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1.Biochemistry. 1998 Sep 15;37(37):12847-51. doi: 10.1021/bi981280m. Biochemistry. 1998. PMID: 9737862
-
Covalent heme binding to CYP4B1 via Glu310 and a carbocation porphyrin intermediate.Biochemistry. 2003 Apr 22;42(15):4601-6. doi: 10.1021/bi020667t. Biochemistry. 2003. PMID: 12693958
-
Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.Arch Biochem Biophys. 1994 Nov 1;314(2):367-75. doi: 10.1006/abbi.1994.1455. Arch Biochem Biophys. 1994. PMID: 7979377
-
CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism.Drug Metab Rev. 2006;38(3):451-76. doi: 10.1080/03602530600688503. Drug Metab Rev. 2006. PMID: 16877261 Review.
-
Spotlight on CYP4B1.Int J Mol Sci. 2023 Jan 20;24(3):2038. doi: 10.3390/ijms24032038. Int J Mol Sci. 2023. PMID: 36768362 Free PMC article. Review.
Cited by
-
ω- versus (ω-1)-hydroxylation: Cytochrome P450 4B1 sterics make the call.J Biol Chem. 2017 Mar 31;292(13):5622-5623. doi: 10.1074/jbc.H117.775494. J Biol Chem. 2017. PMID: 28363936 Free PMC article.
-
Systematic engineering pinpoints a versatile strategy for the expression of functional cytochrome P450 enzymes in Escherichia coli cell factories.Microb Cell Fact. 2023 Oct 25;22(1):219. doi: 10.1186/s12934-023-02219-7. Microb Cell Fact. 2023. PMID: 37880718 Free PMC article.
-
Glutamine-451 Confers Sensitivity to Oxidative Inhibition and Heme-Thiolate Sulfenylation of Cytochrome P450 4B1.Chem Res Toxicol. 2019 Mar 18;32(3):484-492. doi: 10.1021/acs.chemrestox.8b00353. Epub 2019 Feb 11. Chem Res Toxicol. 2019. PMID: 30701961 Free PMC article.
-
Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo.Drug Metab Dispos. 2012 Jan;40(1):54-63. doi: 10.1124/dmd.111.039347. Epub 2011 Oct 5. Drug Metab Dispos. 2012. PMID: 21976622 Free PMC article.
-
CYP4V2 in Bietti's crystalline dystrophy: ocular localization, metabolism of ω-3-polyunsaturated fatty acids, and functional deficit of the p.H331P variant.Mol Pharmacol. 2012 Oct;82(4):679-86. doi: 10.1124/mol.112.080085. Epub 2012 Jul 6. Mol Pharmacol. 2012. PMID: 22772592 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources